Clin2
NCT07770464Possibly a fitRecruiting

Montelukast for acute bronchiolitis in infants

Acute Bronchiolitis

Treatments studied

Part of Lungs & breathing clinical trials.

This study tests whether montelukast, a medicine that helps reduce airway inflammation, can improve symptoms of acute bronchiolitis (a common lung infection in babies) when given early. It may help babies breathe easier and recover faster.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
4 weeks to 2 years
Study type
Interventional

Who can take part

  • Your baby is between 4 weeks and 2 years old
  • Your baby has had breathing symptoms for less than 4 days
  • Your baby has been diagnosed with acute bronchiolitis
  • Your baby does not have a history of asthma or previous hospital stays for breathing problems
  • Your baby is not taking asthma medications
  • Your baby does not have heart disease, lung problems from prematurity, a weakened immune system, or pneumonia (confirmed by chest X-ray)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07138625Not yet recruiting
Saltwater mist for babies with bronchiolitis

This study tests whether breathing in a salty mist helps babies with bronchiolitis recover faster than a plain water mist. It could ease breathing and reduce hospital stay.

NCT07101640Recruiting· Phase 1/Phase 2
Montelukast study for breathing problems in premature infants

This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.

Little Rock, Arkansas
NCT06946264Recruiting· Phase 3
Treating Bronchiolitis: How Babies Respond to Breathing Medicine

This study looks at how children with bronchiolitis (a common lung infection in babies) respond to breathing treatments. It will also check if genes or other traits play a role. The goal is to better understand which treatments work best.

Orlando, Florida
NCT07675252Not yet recruiting· Phase 4
Inhaled steroid for wheezing in infants under 2

This trial tests whether a nebulized (inhaled mist) steroid medicine called fluticasone propionate helps reduce wheezing in infants under 2 years old. It aims to see if this treatment is safe and effective for babies who are hospitalized with wheezing.

NCT06506474Recruiting
A study on care for babies hospitalized with bronchiolitis

This trial looks at how doctors treat babies hospitalized with bronchiolitis. It aims to understand which treatments are really needed and where care could be improved. If your baby was recently admitted for bronchiolitis, this study might help future babies get better, simpler care.

Calgary, Alberta
NCT06689631Not yet recruiting
Breathing physiotherapy for acute bronchiolitis in babies

This study tests breathing physiotherapy techniques to clear mucus from the airways in babies with bronchiolitis (a chest infection causing cough and wheeze). It aims to see if these gentle techniques help babies recover faster.

Hear when a new Acute Bronchiolitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.